Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes

Overview of attention for article published in Journal of Clinical Oncology, June 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 2 X users

patent: 9 patents
facebook: 1 Facebook page
f1000: 1 research highlight platform

Readers on

mendeley: 198 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 9 patents that reference this research output.

Soluble CD33 for treating myelodysplastic syndromes (MDS)

Grant US-11584787-B2

United States of America

21 Feb 2023

Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid…

Grant US-11547696-B2

United States of America

10 Jan 2023

Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

Grant US-11542261-B2

United States of America

03 Jan 2023

Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

Grant US-11254667-B2

United States of America

22 Feb 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.